Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: UK's Unilabs-HIS to Provide Roche HPV Test

Premium

Roche said this week that it has signed a co-marketing deal with London-based pathology and molecular diagnostic lab Unilabs-IHS to provide Roche's Cobas HPV test to women in the UK.

Unilabs will provide the test as a follow-up to traditional Pap cervical smears and, upon request, as a primary screen for cervical pre-cancer.

The Cobas HPV test runs on the company's Cobas 4800 automated molecular testing system and individually identifies genotypes 16 and 18, the highest risk types associated with the development of cervical cancer and its precursor lesions, as well as 12 other high-risk HPV types as a pooled result.

Roche launched the assay in 2009 in countries that accept the CE Mark. The US Food and Drug Administration cleared the assay for marketing in April 2011.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.